Swanson J, Fragkoudis R, Hawes P C, Newman J, Burman A, Panjwani A, Stonehouse N J, Tuthill T J (2021)
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
Life 11 (4) , 338
Publisher’s version: https://doi.org/10.3390/life11040338
Chandler-Bostock R, Mata C P, Bingham R J, Dykeman E C, Meng B, Tuthill T J, Rowlands D J, Ranson N A, Twarock R, Stockley P G
(2020)
Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts
PLoS Pathogens 16 (12) , e1009146
Publisher’s version: https://doi.org/10.1371/journal.ppat.1009146
Tan T K, Rijal P, Rahikainen R, Keeble A H, Schimanski L, Hussain S, Harvey R, Hayes J W P, Edwards J C, McLean R K, Martini V, Pedrera M, Thakur N, Conceicao C, Dietrich I, Shelton H, Ludi A, Wilsden G, Browning C, Zagrajek A K, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Tully M, Moffat K, Chiu C, Waters R, Gray A, Azhar M, Mioulet V, Newman J, Asfor A S, Burman A, Crossley S, Hammond J A, Tchilian E, Charleston B, Bailey D, Tuthill T J, Graham S P, Duyvesteyn H M E, Malinauskas T, Huo J, Tree J A, Buttigieg K R, Owens R J, Carroll M W, Daniels R S, McCauley J W, Stuart D I, Huang K A, Howarth M, Townsend A R (2021)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Nature Communications 12 , 542
Publisher’s version: https://doi.org/10.1038/s41467-020-20654-7
Folegatti P M, Ewer K J, Aley P K, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck E A, Dold C, Faust S N, Finn A, Flaxman A L, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian A M, Pollock K M, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas A D, Hill A V S, Lambe T, Gilbert S C, Pollard A J, on behalf of Oxford COVID Vaccine Trial Group (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
The Lancet 396 (10249) , 467-478
Publisher’s version: https://doi.org/10.1016/S0140-6736(20)31604-4
Ward J C, Lasecka-Dykes L, Neil C, Adeyemi O, Gold S, McLean N, Wright C, Herod M R, Kealy D, Warner E, King D P, Tuthill T J, Rowlands D J, Stonehouse N J
(2020)
The RNA pseudoknots in foot-and-mouth disease virus are dispensable for genome 1 replication but essential for the production of infectious virus.
bioRxiv , 901801
Publisher’s version: https://doi.org/10.1101/2020.01.10.901801